# Alefacept in Patients With Severe Scalp Alopecia Areata

> **NCT00167102** · NA · COMPLETED · sponsor: **University of Minnesota** · enrollment: 45 (actual)

## Conditions studied

- Alopecia Areata

## Interventions

- **DRUG:** Alefacept

## Key facts

- **NCT ID:** NCT00167102
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2019-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00167102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00167102, "Alefacept in Patients With Severe Scalp Alopecia Areata". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00167102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*